Journal of Emergency Medicine Case Reports

2149-9934

Acil Tıp Uzmanları Derneği

10.33706/jemcr.1087340

Clinical Sciences

Klinik Tıp Bilimleri

A case of new-onset refractory status epilepticus (NORSE) due to Herpes Simplex Virus-1 encephalitis

https://orcid.org/0000-0003-1944-2477

Alkan

Sevil

Çanakkale On sekiz Mart Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Çanakkale

https://orcid.org/0000-0003-0684-4047

Önder

Taylan

Canakkale Onsekiz Mart University Faculty of Medicine, Infectious Disease Department, Canakkale-Turkey

https://orcid.org/0000-0001-5029-9838

Akça

Anıl

Canakkale Onsekiz Mart University Faculty of Medicine, Infectious Disease Department, Canakkale-Turkey

https://orcid.org/0000-0003-2774-8601

Şener

Alper

Izmir Katip Çelebi Research Hospital, Department of Infectious Diseases and Clinical Microbiology, İzmir, Turkey

09 30 2022

13 3 98 100 03 14 2022 06 08 2022

2010

Journal of Emergency Medicine Case Reports

In the medical literature, the term of "new-onset refractory status epilepticus" (NORSE) is a novel term. Herpes Simplex Virus-1 and other viral infections can be cause to NORSE. Seizures are a rare sign of HSV encephalitis, but they can occur as the first symptom. Herein, we present a case of NORSE triggered by HSV-1 encephalitis, which had been diagnosed via cerebrospinal fluid polymerase chain reaction (PCR) method and magnetic resonance imaging findings.

Herpes Simplex Virus encephalitis new-onset refractory status epilepticus seizures

yok

1. Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018; 59: 739–44.

2. Specchio N, Pietrafusa N. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Dev Med Child Neurol 2020;62(8):897-905.

3. Iizuka T, Kanazawa N, Kaneko J, et al. Cryptogenic NORSE: its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm 2017; 4: e396.

4. Bradshaw MJ, Venkatesan A. Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management. Neurotherapeutics 2016;13(3):493-508.

5. Rabinstein AA. Herpes Virus Encephalitis in Adults: Current Knowledge and Old Myths. Neurol Clin 2017;35(4):695-705.

6. Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano J. Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience. Neurol Sci 2013;34(10):1879-81.

7. Fotedar N, Dolbow J, Layfield M, Thyagaraj S, Zande J. Epileptic negative myoclonus in herpes simplex virus encephalitis. Epileptic Disord 2021. doi: 10.1684/epd.2021.1401.

8. Laohathai C, Weber DJ, Hayat G, Thomas FP. Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient. Infection 2016;44(1):121-5.

9. Michael BD, Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia. 2012 Sep;53 Suppl 4:63-71.

10. Herpes Simplex Encephalitis. https://emedicine.medscape.com/article/1165183-overview. [Accessed 10 February 2022].

11. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008;49 Suppl 6:13-8.

12. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NWS, Hart IJ, et al, On behalf of the National Encephalitis Guidelines Development Group. Management of suspected viral encephalitis in adults: Association of British Neurologists and British Infection Association National Guideline. J Infect 2012; 64:347–73.